Opti Capital Management, LP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 33 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Opti Capital Management, LP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$8,782,000
+31.5%
8,722,000
+29.8%
0.82%
+15.1%
Q2 2021$6,676,000
+63.1%
6,722,000
+49.4%
0.72%
+42.9%
Q3 2020$4,093,000
-44.7%
4,500,000
+52841.2%
0.50%
-60.4%
Q2 2020$7,400,0008,5001.26%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 40,000,000$39,863,0001.36%
TFG Asset Management GP Ltd 21,600,000$21,837,0001.32%
Penn Mutual Asset Management 810$806,0000.86%
WOLVERINE ASSET MANAGEMENT LLC 47,643,000$47,931,0000.45%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,750,0000.25%
OAKTREE CAPITAL MANAGEMENT LP 18,672,000$18,683,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 9,833,000$9,883,0000.20%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 10,000,000$9,956,0000.15%
SSI INVESTMENT MANAGEMENT LLC 2,500,000$2,490,0000.15%
AVIVA PLC 31,500,000$31,724,0000.13%
View complete list of LIGAND PHARMACEUTICALS INC shareholders